Kevin Leffers, PharmD

Articles by Kevin Leffers, PharmD

3D illustration of lung x-ray | Image Credit: © Vector Market - stock.adobe.com

Advancing Frontline Care for EGFR-Mutated NSCLC: Updates on Amivantamab With Lazertinib

ByKevin Leffers, PharmD,Nicole Bentivegna, PharmD, BCOP

February 16th 2026

Amivantamab with lazertinib emerges as a promising frontline therapy for EGFR-mutated metastatic NSCLC, enhancing overall survival and treatment tolerability.

Latest Updated Articles

Advancing Frontline Care for EGFR-Mutated NSCLC: Updates on Amivantamab With Lazertinib
February 16th 2026

Kevin Leffers, PharmD

Articles by Kevin Leffers, PharmD

Advancing Frontline Care for EGFR-Mutated NSCLC: Updates on Amivantamab With Lazertinib

Latest Updated Articles

Trending on Pharmacy Times

Overcoming Barriers to Kidney-Protective Therapy

Why Blood Pressure Won't Budge—and How Pharmacists Help

Night Shift Work, Chronic Insomnia Nearly Triple Long-COVID Risk, Study Finds

FDA Grants Fast Track Designation to Safusidenib for IDH1-Mutant Glioma

Biosimilars: A Guide for Pharmacists